Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism

Clinical trial NCT06465108 · COMPLETED

Trial details

NCT number: NCT06465108
Sponsor: MBX Biosciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypoparathyroidism

Start date: 2024-08-08
Primary completion: 2025-05-23
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.